Philip Herman
Corporate Officer/Principal en REPARE THERAPEUTICS INC. .
Fortuna: 12 361 $ al 30/04/2024
Perfil
Philip Karl Herman is currently the Executive VP-Commercial & New Product Development at Repare Therapeutics, Inc. He previously worked as the Marketing Director at Vanda Pharmaceuticals, Inc. and as the Vice President, Head-Commercial & Marketing at Dyax Corp.
From 2018 to 2021, he served as the Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. Mr. Herman holds an MBA degree from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.01% | 01/04/2024 | 3 924 ( 0.01% ) | 12 361 $ | 30/04/2024 |
Cargos activos de Philip Herman
| Empresas | Cargo | Inicio |
|---|---|---|
| REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 05/01/2022 |
Antiguos cargos conocidos de Philip Herman.
| Empresas | Cargo | Fin |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2021 |
| VANDA PHARMACEUTICALS INC. | Ventas & Marketing | - |
| DYAX CORP. | Ventas & Marketing | - |
Formación de Philip Herman.
| Kellogg School of Management | Masters Business Admin |
| Baldwin Wallace University School of Business | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Herman
